IRIDEX CFO buys 7,900 shares at $0.63

IRIDEX CORP (IRIX) reported that Chief Financial Officer Romeo R. Dizon purchased 7,900 shares of common stock on September 16, 2026 in an open market or private transaction at $0.63 per share.

Rhea-AI Filing Summary

IRIDEX CORP (IRIX) reported that Chief Financial Officer Romeo R. Dizon purchased 7,900 shares of common stock on September 16, 2026 in an open market or private transaction at $0.63 per share. Following this purchase, he directly holds 185,306 shares of IRIDEX common stock. No Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Net Buyer: 7,900 shares

Net Buy 1 txn

Insider Dizon Romeo R

Role Chief Financial Officer

Bought 7,900 shs ($5K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	7,900	$0.63	$5K

Holdings After Transaction: Common Stock — 185,306 shares (Direct)

Key Figures

Shares purchased: 7,900 shares Purchase price per share: $0.63 per share Shares owned after transaction: 185,306 shares

3 metrics

Shares purchased 7,900 shares Common stock bought on September 16, 2026

Purchase price per share $0.63 per share Open market or private transaction by CFO

Shares owned after transaction 185,306 shares Direct holdings of CFO following the purchase

Key Terms

open market or private transaction, Rule 10b5-1 trading plan, direct ownership

3 terms

open market or private transaction financial

"Purchase in open market or private transaction"

Rule 10b5-1 trading plan regulatory

"No Rule 10b5-1 trading plan is reported"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

direct ownership financial

"The Form 4 shows the CFO’s post-transaction holdings as direct ownership"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did IRIX report for its CFO?

IRIDEX CORP reported that CFO Romeo R. Dizon purchased 7,900 shares of IRIX common stock on September 16, 2026 at $0.63 per share in an open market or private transaction.

How many IRIX shares does the CFO own after this Form 4 transaction?

After the reported purchase, CFO Romeo R. Dizon directly owns 185,306 shares of IRIDEX CORP common stock, according to the Form 4 filing.

Was the September 16, 2026 IRIX insider trade made under a Rule 10b5-1 plan?

No. The filing indicates no Rule 10b5-1 trading plan for the reported transaction by IRIDEX CORP’s chief financial officer.

What price did the IRIX CFO pay per share in the latest Form 4 filing?

The chief financial officer of IRIDEX CORP purchased the shares at $0.63 per share on September 16, 2026.

Is the IRIX CFO’s ownership direct or indirect after this transaction?

The Form 4 shows the CFO’s post-transaction holdings of 185,306 shares as direct ownership of IRIDEX CORP common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/16/2026 - 04:27 PM Accepted by SEC EDGAR 09/16/2026 - 04:26 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dizon Romeo R

(Last) (First) (Middle)

1212 TERRA BELLA AVENUE

(Street)

MOUNTAIN VIEW CALIFORNIA 94043

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/16/2026		P		7,900	A	$0.63	185,306	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Nilo De Castro, Attorney-in-fact for Romeo R. Dizon	09/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)